13. Drugs for Cardiac Arrhythmias, Antithrombotic Drugs and Lipid Modulating Drugs
Sheila A Doggrell
Discipline of Medical Sciences, Faculty of Science and Technology, Queensland University of Technology, Gardens Point, GPO Box 2434, QLD 4001, Australia
Phone +61 7 38705741 Fax +61 7 31381534 Email sheila.doggrell@qut.edu.au
Reviewer required
Key words: cardiac arrhythmia, cardiac action potential, Class I-IV, lignocaine, esmolol, d-sotalol, verapamil, amiodarone, adenosine, antithrombotic, antiplatelet drugs, aspirin, clopidogrel, abciximab, anticoagulants, heparin, enoxaparin, warfarin, dabigatran, fondaparinux, fibrinolytics, streptokinase, alteplase, lipid-modulating drugs, simvastatin, gemfibrozil, ezetimibe
Contents
13.1 Drugs for cardiac arrhythmias
13.1.1 Introduction to cardiac arrhythmias
13.1.2 Cardiac action potentials
13.1.3 Mechanisms of cardiac arrhythmias
13.1.3 Class I
13.1.4 Class II
13.1.5 Class III
12.1.6 Class IV
13.1.7 Amiodarone
13.1.8 Adenosine
13.2 Antithrombotic drugs
13.2.1 Thrombus formation
13.2.2 Platelet aggregation and anti-platelet drugs
13.2.3 Coagulation
13.2.4 Anticoagulants
13.2.5 Fibrinolysis and fibrinolytics
13.3. Lipid modulating drugs
13.3.1 Cholesterol
13.3.2 Statins
13.3.3 Fibric acid derivatives
13.3.4 Ezetimibe
Drugs for cardiac arrhythmias, antithrombotic drugs and lipid modify drugs are considered in this section.